{"id":3958,"date":"2021-04-22T17:29:39","date_gmt":"2021-04-22T16:29:39","guid":{"rendered":"https:\/\/world-heart-federation.org\/?page_id=3958"},"modified":"2021-04-23T15:52:54","modified_gmt":"2021-04-23T14:52:54","slug":"wikimeds","status":"publish","type":"page","link":"https:\/\/world-heart-federation.org\/emerging-leaders\/projects\/wikimeds\/","title":{"rendered":"WikiMeds"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"
Increasing Transparency to Promote the use of Medicines for Secondary Prevention of Cardiovascular Disease<\/p>\n","protected":false},"author":1,"featured_media":4028,"parent":2203,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/flexible-template.php","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"topic":[],"class_list":["post-3958","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\n